Composite Herbal Tea Supplement for Respiratory Virus Symptoms

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a high demand for effective relief of COVID-19 symptoms, as existing treatments like antiviral medications and over-the-counter medications have minimal impact, and there is a lack of specific treatments for severe cases.

Innovation Solution

A dietary supplement comprising Fructus tsaoko, Rhizoma polygoni cuspidati, Radix scutellariae, Rhizoma anemarrhenae, Cortex magnoliae officinalis, Radix paeoniae alba, Rhizoma atractylodis, Herba agastaches/Pogostemonis, Semen armeniacae, Fructus trichosanthis, Radix astragali, Radix angelicae sinensis, Flos lonicerae, and Radix glycyrrhizae, formulated into a tea, which is consumed by individuals infected with SARS-CoV-2.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antiviral medications and over-the-counter medications are used, then treatment options are available, but the effectiveness is minimal and no clear impact on mortality

Engineering Contradiction:
Improveeffectiveness of treatmentVSAvoidlack of impact on mortality
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent changes the parameter of treatment approach by transitioning from conventional antiviral and over-the-counter medications to a traditional Chinese medicine formula. This parameter change involves altering the fundamental mechanism of action from synthetic pharmaceuticals to natural herbal compounds, thereby addressing the limitation of minimal effectiveness and lack of mortality impact.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs a composite material approach by combining multiple traditional Chinese medicine ingredients (Fructus tsaoko, Rhizoma polygoni cuspidati, Radix scutellariae, etc.) into a synergistic formula. This composite herbal composition works together to address COVID-19 symptoms, providing a more effective and comprehensive treatment approach compared to single-ingredient medications.

Inventive Principle:
Principle #40Composite materials

2Duration of action of moving object

If remdesivir is used for severe COVID-19 cases, then recovery time may be affected, but the treatment is complex and requires emergency use authorization

Engineering Contradiction:
Improverecovery timeVSAvoidtreatment complexity
Core Design Contradiction:
Duration of action of moving objectVSDevice complexity

Solution Approach 1:

The patent proposes a simpler, more accessible treatment alternative that can be easily implemented without complex authorization processes. The traditional Chinese medicine formula serves as a straightforward, cost-effective option that patients can access more readily compared to emergency authorized medications like remdesivir.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent extracts the essential therapeutic components from complex modern pharmaceutical interventions and returns to traditional herbal medicine. By taking out the core beneficial elements from the complexity of modern drug authorization and administration, the formula provides a streamlined treatment approach that maintains effectiveness while reducing bureaucratic and procedural complexity.

Inventive Principle:
Principle #2Taking out (Extraction)

3Ease of operation

If over-the-counter cold medications are taken, then symptoms may be alleviated, but the effect is nominal and does not address severe cases

Engineering Contradiction:
Improveease of symptom reliefVSAvoideffectiveness for severe cases
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent creates a universal treatment formula that effectively addresses both mild and severe COVID-19 cases. The traditional Chinese medicine composition serves multiple functions: it alleviates common symptoms like fever and cough while also addressing severe manifestations such as respiratory distress and immune suppression. This multi-functional approach makes the treatment applicable across the full spectrum of disease severity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS12433929B1Dietary supplement for persons infected with a respiratory virus
Publication Date: 2025.10.07 SVA HOLDING CO LLC
  • US12433929B1 patent drawing

AI summary

A dietary supplement comprises the ingredients: Fructus tsaoko (Tsaoko Fruit), Rhizoma polygoni cuspidati (Knotweed), Radix scutellariae (Skullcap), Rhizoma anemarrhenae (Know Mother Root), Cortex magnoliae officinalis (Magnolia Bark), Radix paeoniae alba (White Peony Root), Rhizoma atractylodis (Red Atractylodis), Herba agastaches/Pogostemonis (Patchouli), Semen armeniacae (Apricot Kernel), Fructus trichosanthis (Chinese Cucumber), Radix astragali (Mongolian Milk-Vetch), Radix angelicae sinensis (Female Ginseng), Flos lonicerae (Honeysuckle), and Radix glycyrrhizae (Licorice). These ingredients are dried and integrated into a tea, which is consumed by a person infected or possibly infected with a respiratory virus.